17/Noviembre/2011

CORPORATE PRESENTATION

1. IVI PROJECT:

ORIGIN AND CURRENT SITUATION

PAG. 03

THE BEGINNING

• IVI came into being in 1990 thanks to the efforts of Doctor Pellicer and Doctor Remohí.

• Creation of the first clinic in Valencia, exclusively dedicated to Assisted Reproductive

Medicine.

• Accepting the challenge for specialization and team work in an emerging area of

medicine.

1. IVI PROJECT:

ORIGIN AND CURRENT SITUATION

PAG. 04

• PATIENT SATISFACTION: EXEMPLARY CARE FOR PATIENTS WITH THE BEST

POSSIBLE RESULTS.

• AN INTEGRATED TEAM AND A “SCHOOL” IN THE AREA OF ASSISTED

REPRODUCTION

• SCIENTIFIC PRODUCTIVITY.

• STRONG TIES WITH THE UNIVERSITY AND THE ACADEMIC COMMUNITY.

IMPORTANT ELEMENTS OF THE PROJECT

2.

PAG. 06

MISSION

We are a team of qualified professionals working

on a common project: carrying out reproductive

medicine of the highest order and fostering

research, education and professional excellence.

To be a world-leading team in the field of

reproductive medicine, becoming the most

widespread group with the best clinical results. To

be an international reference point in quality care,

research and teaching. Prioritizing the development

of people and team spirit as the pillars of our

project.

VISION

MISSION, VISION AND VALUES

2.

PAG. 07

VALUES

... These make all of us proud to be part of IVI.

• FREEDOM OF INITIATIVE AND INNOVATION

• DESIRE FOR SELF-IMPROVEMENT

• SATISFACTION FOR A JOB WELL DONE

• TEAM WORK

• HONESTY

• LOYALTY

MISSION, VISION AND VALUES

PAG. 09

3.

• Clinics in 7 countries.

• 27 medical centers.

• 32,000 AR treatments in 2014.

• More than 90,000 births until now.

• Approx. 24% of the patients come from countries where

we do not have any centers.

• Patients from more than 85 countries (historically 106).

Leader in Reproductive Medicine

BASIC FACTS ABOUT THE COMPANY

PAG. 11

3.

IVI Group has more than 1,200 employees on its staff, 83% are women.

IVI Group´s employees

BASIC FACTS ABOUT THE COMPANY

PAG. 13

Valencia (2)

Castellón

Murcia

Cartagena

Madrid (2)

Almería

Sevilla

Barcelona

Vigo

Alicante

Elche

Bilbao

Santander

Las Palmas

Zaragoza

Málaga (2)

San Sebastián

México

Lisbon

Santiago de Chile

Panamá

Buenos Aires

Salvador de Bahía

Sao Paulo

4. WORLDWIDE PRESENCE:

IVI CENTERS

4.

PAG. 17

BARCELONA

Head Doctor:

Dr. Agustín Ballesteros

IVI CLINICS IN THE WORLD:

WORLDWIDE PRESENCE:

IVI CENTERS

6. Research, Education and Social Activity

Development in any area of medicine, and especially in Reproductive Medicine, currently

requires basic research upon which to base its growth and evolution, and needs to be

socially projected in order to inform people who may benefit from these treatments.

FUNDACIÓN IVI was created

as a non-profit organization

in 1997 and since then it has

been widening its scope of

work to develop the three

main pillars that today make

up its backbone:

Investigation, Teaching and

Social Action

PAG. 40

FUNDACIÓN IVI:

A FOUNDATION FULL OF LIFE

6.

Research and development

Headed by Prof. Dr. Carlos Simón A multidisciplinary team of doctors, biologist, chemists, pharmacologists, biochemists, etc. Basic and applied research Private laboratories Cooperation with Universities in Spain and abroad.

PAG. 41

FUNDACIÓN IVI:

A FOUNDATION FULL OF LIFE

6. Research and development – Main activity lines:

• Viability of new means of embryo culture • Ovarian Hyperstimulation Syndrome (OHSS) • Endometriosis • Embryo Implantation: HLA-G gene polymorphism/cell recycling • Genetics/Preimplantational Genetic Diagnosis (PGD) • Embryo quality indicators • Spermatozoa fertility Indicators • Cryopreservation of oocytes and ovarian tissue • Optimization program for ovum donations • Stem cell lines

PAG. 42

FUNDACIÓN IVI:

A FOUNDATION FULL OF LIFE

7.

PAG. 46

ACTIVITY AREAS

Reproduction: Human Sterility Andrology Genetics Endoscopic surgery ART Laboratories: Insemination IVF/ICSI PGD Cryopreservation

Endocrinology Inmunology Central services: Analysis Genetics

Obstetrics/Pediatrics: MFMU: Morphological sonography, High-risk pregnancies

Pediatrics

Women’s health Men’s health Psychology

8. 39 AWARDS AND PRIZES

PAG. 48

AWARDS AND PRIZES

• 8 American Society for Reproductive Medicine (ASRM) awards

• 4 Health 2000

• 12 SEF (Sociedad Española de la Fertilidad)

• 4 SEGO (Sociedad Española de Ginecología y Obstetricia)

• Jaume I award for Clinical Medicine (Prof. Pellicer and Prof. Simón)

• NOVA award (Best Company in Biomedicine Sector) of the C.V

• Gold Medal award of Valencia for Research and Teaching

• “Best Place to Work” – Spain 2008, 2009 y 2010

• “Empresa Revelación de la Comunidad Valenciana” award by the magazine Actualidad

Económica

• “Valencianos Siglo XXI” award of Las Provincias

• 2 ASA (American Society of Andrology)

• Innovation award 2012 (Ernst & Young Entrepreneur Of The Year 2012)

• Jacques Salat-Baroux 2014 award to Prof. Antonio Pellicer from the French National Academy

of Medicine.

9.

PAG. 50

OTHER BUSINESS UNITS:

Web: www.ivi-co.com

9.

PAG. 50

OTHER BUSINESS UNITS:

IGENOMIX

iGenomix, is the company of the IVI Group whose objective is to create and develop diagnostic specific tools to support professionals in the reproductive medicine field. IGenomix, is the company with the most preimplantation genetic diagnosis (PGD) cycles performed in Europe and one of the world references in this type of techniques. IGenomix has its own laboratories outside Spain for meeting the increasing demand for international services, specifically in Delhi (India), Sao Paulo (Brazil) and Dubai. It also has a subsidiary in the US (IVIGEN) with an important presence in the North-American market and laboratories in Miami and Los Angeles as well as with a local associate in Milan (Italy).

PAG. 51

9.

PAG. 50

OTHER BUSINESS UNITS:

IGENOMIX

PAG. 51

9.

PAG. 52

OTHER BUSINESS UNITS:

IVIDA

IVIDA collects, processes, cryopreserves and stores the stem cells of the Umbilical Cord Blood (UCB) for the treatment of different diseases such as lymphomas, leukemias, or anemias. With the guarantee that it will be managed completely by employees of the company (in our own facilities), therefore assuring the traceability and complete control of the whole process.

Cord Blood Bank of the IVI group